Molecular Partners AG (LTS:0QXX)
CHF 4.54 0 (0%) Market Cap: 170.68 Mil Enterprise Value: 29.80 Mil PE Ratio: 0 PB Ratio: 1.11 GF Score: 48/100

Half Year 2024 Molecular Partners AG Earnings Call Transcript

Aug 27, 2024 / 12:00PM GMT
Release Date Price: CHF5.4
Operator

Good day and welcome to the Molecular Partners first half 2024 results conference call. (Operator Instructions) Please note today's event is being recorded. I'd now like to turn the conference over to Seth Lewis, Senior Vice President, Investor Relations. Please go ahead.

Seth Lewis
Molecular Partners AG - Senior Vice President - Investor Relations, Communications and Strategy

Thanks, Rocco. Good morning and good afternoon, everyone. Welcome to the Molecular Partners first half 2024 results call. My name is Seth Lewis, Senior Vice President of Investor Relations, and I'm joined this morning by Patrick Amstutz, CEO; Philippe Legenne, Chief Medical Officer; Daniel Steiner, Senior Vice President, Research and Technology; and Robert Hendriks, Senior Vice President of Finance.

Management will take a few minutes to make brief remarks, and then we will open up for question and answer period. If you have not had a chance to review the H1 press release, please feel free to do so on our website,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot